AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842 | +24.6% | 739 | 0.0% | 0.00% | – |
| Q2 2023 | $676 | +63.3% | 739 | 0.0% | 0.00% | – |
| Q1 2023 | $414 | – | 739 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 739 | -23.3% | 0.00% | – |
| Q3 2022 | $0 | – | 963 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 963 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 963 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 963 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -93.9% | 963 | -92.6% | 0.00% | – |
| Q2 2021 | $49,000 | +8.9% | 13,056 | 0.0% | 0.00% | – |
| Q1 2021 | $45,000 | +25.0% | 13,056 | +0.8% | 0.00% | – |
| Q4 2020 | $36,000 | +800.0% | 12,956 | +679.5% | 0.00% | – |
| Q3 2020 | $4,000 | -92.5% | 1,662 | -57.5% | 0.00% | – |
| Q2 2020 | $53,000 | -41.1% | 3,909 | -67.1% | 0.00% | – |
| Q1 2020 | $90,000 | – | 11,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |